Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John L Hopper

Showing results (561-570 of 894) with videos related to

Pageof 90
Sort By:
Gastroenterology|January 22, 2014
Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancerAung Ko Win, James G Dowty, Sean P Cleary, et al.
BMJ Open|February 21, 2016
Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry CohortChristophe Rosty, Mark Clendenning, Michael D Walsh, et al.
JNCI Cancer Spectrum|December 20, 2019
Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management ToolKelly-Anne Phillips, Yuyan Liao, Roger L Milne, et al.
International Journal of Epidemiology|March 9, 2018
Genome-wide average DNA methylation is determined in uteroShuai Li, Ee Ming Wong, Pierre-Antoine Dugué, et al.
Familial Cancer|June 19, 2019
Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family historyMark A Jenkins, Aung K Win, James G Dowty, et al.
Breast Cancer Research : BCR|April 20, 2019
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort studyRebecca D Kehm, John L Hopper, Esther M John, et al.
American Journal of Human Genetics|September 29, 2009
Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancerSean V Tavtigian, Peter J Oefner, Davit Babikyan, et al.
Clinical Epigenetics|June 3, 2023
Identifying primary and secondary MLH1 epimutation carriers displaying low-level constitutional MLH1 methylation using droplet digital PCR and genome-wide DNA methylation profiling of colorectal cancersJihoon E Joo, Khalid Mahmood, Romy Walker, et al.
Cancer Research|October 4, 2019
Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic RiskRebecca D Kehm, Jeanine M Genkinger, Robert J MacInnis, et al.
Genetic Epidemiology|July 20, 2011
A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impactRobert J Macinnis, Antonis C Antoniou, Rosalind A Eeles, et al.
Pageof 90

Showing results (561-570 of 894) with videos related to

Sort By:
Pageof 90
Gastroenterology|January 22, 2014
Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancerAung Ko Win, James G Dowty, Sean P Cleary, et al.
BMJ Open|February 21, 2016
Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry CohortChristophe Rosty, Mark Clendenning, Michael D Walsh, et al.
JNCI Cancer Spectrum|December 20, 2019
Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management ToolKelly-Anne Phillips, Yuyan Liao, Roger L Milne, et al.
International Journal of Epidemiology|March 9, 2018
Genome-wide average DNA methylation is determined in uteroShuai Li, Ee Ming Wong, Pierre-Antoine Dugué, et al.
Familial Cancer|June 19, 2019
Ability of known susceptibility SNPs to predict colorectal cancer risk for persons with and without a family historyMark A Jenkins, Aung K Win, James G Dowty, et al.
Breast Cancer Research : BCR|April 20, 2019
Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort studyRebecca D Kehm, John L Hopper, Esther M John, et al.
American Journal of Human Genetics|September 29, 2009
Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancerSean V Tavtigian, Peter J Oefner, Davit Babikyan, et al.
Clinical Epigenetics|June 3, 2023
Identifying primary and secondary MLH1 epimutation carriers displaying low-level constitutional MLH1 methylation using droplet digital PCR and genome-wide DNA methylation profiling of colorectal cancersJihoon E Joo, Khalid Mahmood, Romy Walker, et al.
Cancer Research|October 4, 2019
Recreational Physical Activity Is Associated with Reduced Breast Cancer Risk in Adult Women at High Risk for Breast Cancer: A Cohort Study of Women Selected for Familial and Genetic RiskRebecca D Kehm, Jeanine M Genkinger, Robert J MacInnis, et al.
Genetic Epidemiology|July 20, 2011
A risk prediction algorithm based on family history and common genetic variants: application to prostate cancer with potential clinical impactRobert J Macinnis, Antonis C Antoniou, Rosalind A Eeles, et al.
Pageof 90